Evidence map›Paper›PMID 35069779›Full record

ArticleComputational and mathematical methods in medicine2022

Forecasting the Severity of COVID-19 Pandemic Amidst the Emerging SARS-CoV-2 Variants: Adoption of ARIMA Model.

Cai Li, Agyemang Kwasi Sampene, Fredrick Oteng Agyeman, Brenya Robert, Abraham Lincoln Ayisi

Abstract read
In one paragraph

Article in Computational and mathematical methods in medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Cai LiSchool of Management, Jiangsu University, Zhenjiang 212013, China.
Agyemang Kwasi SampeneSchool of Management, Jiangsu University, Zhenjiang 212013, China.ORCID https://orcid.org/0000-0002-0475-7700
Fredrick Oteng AgyemanSchool of Management, Jiangsu University, Zhenjiang 212013, China.ORCID https://orcid.org/0000-0003-4615-2555
Brenya RobertCollege of Economics and Management, Nanjing Agricultural University, Nanjing 210095, China.ORCID https://orcid.org/0000-0003-1054-0871
Abraham Lincoln AyisiSchool of Finance and Economics Zhenjiang, Jiangsu 212013, China.ORCID https://orcid.org/0000-0002-0268-6742

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Currently, the global report of COVID-19 cases is around 110 million, and more than 2.43 million related death cases as of February 18, 2021. Viruses continuously change through mutation; hence, different virus of SARS-CoV-2 has been reported globally. The United Kingdom (UK), South Africa, Brazil, and Nigeria are the countries from which these emerged variants have been notified and now spreading globally. Therefore, these countries have been selected as a research sample for the present study. The datasets analyzed in this study spanned from March 1, 2020, to January 31, 2021, and were obtained from the World Health Organization website. The study used the Autoregressive Integrated Moving Average (ARIMA) model to forecast coronavirus incidence in the UK, South Africa, Brazil, and Nigeria. ARIMA models with minimum Akaike Information Criterion Correction (AICc) and statistically significant parameters were chosen as the best models in this research. Accordingly, for the new confirmed cases, ARIMA (3,1,14), ARIMA (0,1,11), ARIMA (1,0,10), and ARIMA (1,1,14) models were chosen for the UK, South Africa, Brazil, and Nigeria, respectively. Also, the model specification for the confirmed death cases was ARIMA (3,0,4), ARIMA (0,1,4), ARIMA (1,0,7), and ARIMA (Brown); models were selected for the UK, South Africa, Brazil, and Nigeria, respectively. The results of the ARIMA model forecasting showed that if the required measures are not taken by the respective governments and health practitioners in the days to come, the magnitude of the coronavirus pandemic is expected to increase in the study's selected countries.

Indexed as

Epidemiological ModelsPandemicsSARS-CoV-2BrazilComputational BiologyConfidence IntervalsCOVID-19ForecastingHumansIncidenceModels, StatisticalNigeriaRegression AnalysisSeverity of Illness IndexSouth AfricaUnited Kingdom

Identifiers

PMID35069779
PMCPMC8776442

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.